LetterRemission and time of resolution of nail psoriasis during infliximab therapy
References (5)
- et al.
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomized trial
Lancet
(2001) - et al.
Pharmacodynamic and pharmacokinetic response to anti-tumor necrosis factor-α monoclonal antibody (infliximab) treatment of moderate to severe psoriasis vulgaris
J Am Acad Dermatol
(2003)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2005 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.